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Summary
Background: S. cerevisiae cells must grow to a critical
size in G1 in order to pass start and enter the cell cycle.
A recent study proposed that in addition to the mother
size control in G1, the bud must grow to a critical bud
size in G2 in order to enter mitosis. Insufficient bud size
would cause G2 arrest enforced by the mitotic inhibitor
Swe1p, explaining previous findings that some pertur-
bations that block bud growth also trigger Swe1p-
dependent cell-cycle arrest.
Results: We tested the critical-bud-size hypothesis. We
found that halting bud growth by inactivation of the
myosin Myo2p did not trigger Swe1p-dependent arrest
in budded cells, even when the buds were very small.
Moreover, Swe1p did not affect cell-cycle progression
in unstressed cells, even when bud size was decreased
by overriding G1 size control. Actin depolymerization did
cause Swe1p-dependent arrest in small-budded but not
large-budded cells, as previously reported. However, we
found that the key determinant of cell-cycle arrest in
those circumstances was not bud size, but rather the rel-
ative abundance of the Swe1p mitotic inhibitor and the
mitosis-promoting cyclins.
Conclusions: Swe1p does not respond to insufficient
bud size. Instead, actin stress empowers Swe1p to pro-
mote arrest. The effectiveness of Swe1p in promoting
that arrest declines as cells progress through the cell
cycle.
Introduction
Proliferating cells maintain a moderately uniform cell
size by making key cell-cycle transitions dependent on
achievement of a minimum ‘‘critical size’’ [1]. Saccharo-
myces cerevisiae cells must reach a critical size during
G1 before passing start and embarking on bud forma-
tion and DNA replication [2], whereas Schizosaccharo-
myces pombe cells must reach a critical size during
G2 before entering mitosis [3]. The term ‘‘size’’ is used
loosely, and what is actually monitored by yeast cells
may be the overall rate of protein synthesis [4].
Initial clues to the identity of the cell-cycle regulators
responsive to cell size came from the identification of
mutants that proceed through the relevant cell-cycle
transition without delaying until the cells attain the criti-
cal size. In budding yeast, gain-of-function CLN3 mu-
tants pass start at abnormally small cell size [5–7].
Cln3p is a G1 cyclin that activates the cyclin-dependent
*Correspondence: daniel.lew@duke.edukinase Cdc28p, promoting passage through start [8, 9],
and it is thought that S. cerevisiae G1 cells must grow to
a critical size to accumulate enough Cln3p to pass start.
In fission yeast, loss-of-functionwee1mutants enter mi-
tosis at abnormally small cell size [3]. Wee1 is a tyrosine
kinase that phosphorylates and inhibits cdc2 in complex
with mitotic cyclins, blocking entry into mitosis [10]. It is
thought that S. pombe G2 cells must grow to a critical
size to overcome the block imposed by Wee1.
In addition to the major size control at start, a re-
cent study proposed the existence of a second size con-
trol coordinating growth and cell-cycle progression in
S. cerevisiae [11]. As in S. pombe, the novel size control
was proposed to occur in G2 and involve the Wee1 ho-
molog, Swe1p [12]. Rather than assessing overall cell
size, S. cerevisiae cells were proposed to monitor bud
size (regardless of mother size) and to need a critical
bud size to overcome the block imposed by Swe1p [11].
Previous work had shown that Swe1p is the key trans-
ducer of the morphogenesis checkpoint, which delays
nuclear division when bud formation is impaired by var-
ious stresses [13]. Rapid changes in a yeast cell’s envi-
ronment trigger a stress response involving transient
depolarization of the actin cytoskeleton, and this depo-
larization leads to transient cessation of bud emergence
and bud growth [14–17]. During this period, Swe1p en-
forces a compensatory delay in nuclear division, thereby
maintaining coordination between bud formation and
cell-cycle progression [13]. These findings have been in-
terpreted as indicative that perturbations of actin orga-
nization enlist Swe1p to arrest the cell cycle [18].
One well-characterized perturbation leading to
Swe1p-mediated cell-cycle arrest is the depolymeriza-
tion of actin by treatment with Latrunculin (Lat) [18, 19].
Upon Lat treatment, unbudded and small-budded cells
arrest in G2, whereas large-budded cells do not [11,
18]. This observation is readily accounted for by the hy-
pothesis that Swe1p blocks entry into mitosis until a crit-
ical bud size has been attained. Because Lat treatment
halts bud growth [20], cells with buds below the critical
size would arrest in response to Lat, whereas cells with
buds above the critical size would not. On the basis of
this rationale, Harvey and Kellogg proposed that rather
than responding to cytoskeletal stress, Swe1p responds
to insufficient bud size [11]. In support of that hypothesis,
they reported that Swe1p delays nuclear division even in
the absence of any stressful perturbation, suggesting
that it acts in every cell cycle rather than only following
stress.
In this report, we present a detailed assessment of the
critical-bud-size hypothesis. We find that when bud
growth is halted by inactivation of the myosin Myo2p
(rather than by Lat treatment), there is no cell-cycle ar-
rest in small-budded cells. Such cells still arrest in re-
sponse to Lat treatment, even though that treatment
has no further effect on bud growth. Moreover, we
show that Swe1p does not detectably influence the
cell cycle of unstressed cells, even when expression of
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2191Figure 1. Insufficient Bud Size Does Not Cause Cell-Cycle Arrest
(A) Wild-type (DLY6712), swe1D (DLY6652), myo2-16 (DLY6603), and myo2-16 swe1D (DLY6653) strains were grown to exponential phase in
YEPD at 24ºC. a-factor was added to block further bud formation, and 15 min later cells were shifted to 37ºC to inactivate Myo2-16p (t = 0). Sam-
ples taken at 15 min intervals were fixed and stained to visualize nuclei. The percentage of budded preanaphase cells that had not yet undergone
nuclear division was scored as described in Experimental Procedures (n > 1000 cell bodies for each sample).
(B) The same strains were treated as above, except for the addition of Latrunculin (black bars) or dimethyl sulfoxide control (white bars) at the
time of shift to 37ºC. The percentage of budded preanaphase cells remaining at 90 min is indicative of Latrunculin-induced cell-cycle arrest.
(C) Representative cells from the experiment in (B), photographed to overlay DNA staining (white) and cell morphology.
(D) cdc24-1 swe1D (DLY690),myo2-16 swe1D (DLY6653), cdc24-1 (DLY657), andmyo2-16 (DLY6603) strains were grown to exponential phase in
YEPD at 24ºC, arrested in G1 with a-factor, and released into fresh YEPD at 37ºC. Samples taken at 30 min intervals were fixed and stained to
visualize nuclei. Nuclear division is plotted (n > 1000 cells for each sample).excess Cln3p bypasses start size control, rendering
cells (and buds) unusually small. Thus, insufficient bud
size does not trigger Swe1p-mediated cell-cycle arrest.
Rather, cytoskeletal perturbations trigger pathways that
promote Swe1p-mediated arrest. To explain why larger-
budded cells do not arrest in response to Lat treatment,
we suggest that such cells have accumulated too much
mitotic cyclin to be effectively inhibited by the available
Swe1p. Consistent with this hypothesis, we find that ei-
ther doubling of the SWE1 gene dosage or removal of
one of the mitotic cyclins allows Lat treatment to arrest
the cell cycle in larger-budded cells.
Results and Discussion
Blocking Bud Growth Does Not Trigger
Cell-Cycle Arrest
The finding that small-budded but not large-budded
cells undergo Swe1p-dependent cell-cycle arrest upon
Lat treatment [11, 18] suggests that bud size might deter-
mine whether or not cells arrest following stress. Lattreatment depolymerizes actin and causes the cessation
of bud growth because the type V myosin Myo2p can no
longer deliver secretory vesicles to the bud along actin
cables [20, 21]. To ask whether cessation of Myo2p-
mediated delivery was sufficient to cause Swe1p-
dependent cell-cycle arrest, we used the temperature-
sensitive myo2-16 mutant [21]. Like Lat treatment,
inactivation of Myo2p results in the immediate cessation
of vesicle traffic to the bud [21] and halts bud growth [20],
but Myo2p inactivation does not depolymerize actin.
Asynchronous cultures of wild-type or myo2-16 mu-
tant cells growing exponentially at permissive tempera-
ture were shifted to restrictive temperature and then
fixed at various times and stained to visualize nuclei.
We scored the proportion of budded cells that had not
yet undergone nuclear division at each time point, as de-
scribed in Experimental Procedures. As shown in Figure
1A, there was no indication of cell-cycle arrest in the
myo2-16 mutants, which proceeded through nuclear di-
vision just like the wild-type controls. Furthermore, dele-
tion of SWE1 had no effect on the kinetics of nuclear
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that unlike Lat treatment, loss of Myo2p function does
not trigger Swe1p-dependent arrest in small-budded
cells.
As shown in Figure 1C, even myo2-16 cells with very
small buds continued with nuclear division, in contrast
to Lat-treated small-budded cells, which underwent
Swe1p-dependent arrest. In most small-budded myo2-
16 cells, the nucleus divided entirely within the mother
cell (Figure 1C), which was expected because Myo2p
is also required to traffic astral microtubules into the
bud to orient the mitotic spindle [22]. Similarly, small-
budded swe1D mutants treated with Lat underwent nu-
clear division entirely within the mother rather than along
the mother-bud axis (Figure 1C).
Why doesn’t Myo2p inactivation lead to arrest of
small-budded cells? The simplest possibility is that the
Swe1p-mediated arrest is not a consequence of cessa-
tion of bud growth per se. However, another possibility
is that inadequate bud size does trigger arrest, but that
Myo2p itself is a necessary part of the bud-size-monitor-
ing machinery. If that were the case, myo2-16 mutants
would be incapable of responding to Lat because they
would lack a key element of the bud-size-monitoring
pathway. However, we found that myo2-16 mutants en-
acted a Swe1p-dependent arrest just like wild-type cells
when exposed to Lat (Figures 1B and 1C). Once Myo2-
16p had been inactivated, treatment with Lat had no fur-
ther effect on bud or mother size (data not shown). We
conclude that neither cessation of bud growth nor inad-
equate bud size is sufficient to cause Swe1p-mediated
arrest.
If Swe1p does not respond to bud size, what triggers
arrest in response to Lat? Previous work on the Swe1p
regulator Hsl1p indicated that its activity was responsive
to the change in cell shape that occurs during bud emer-
gence, suggesting that one trigger for Swe1p-depen-
dent arrest is the absence of a bud [23]. We found that
although loss of Myo2p function did not trigger arrest
of budded cells (Figure 1A), it did trigger a Swe1p-
dependent cell-cycle delay in unbudded cells (Figure
1D), consistent with the hypothesis that Swe1p responds
to a block of bud emergence. However, lack of a bud is
not the only stimulus for Swe1p-mediated arrest be-
cause Lat treatment induces cell-cycle arrest in small-
budded cells as well [18].
Swe1p Does Not Impact The Cell Cycle
of Unstressed Cells
The observations described above led us to reinvesti-
gate the question of whether or not Swe1p acts even
in unstressed cells during exponential growth. We took
special care regarding cell density and nutrient levels,
given recent work suggesting that nutrient depletion
can act as an actin-depolarizing stress [24]. During ex-
ponential growth, each generation of cells consumes
twice as many nutrients as its parent generation. As
shown by Lillie and Pringle [25], this means that half of
the glucose in a culture is consumed during a single gen-
eration, leading to a dramatic ‘‘glucose crash.’’ This
does not halt proliferation, because cells approaching
the glucose crash stockpile glycogen, which serves as
a carbon source for further growth [25]. However, recent
work by Uesono et al. [24] revealed that sudden glucosedepletion is a stress that triggers actin depolarization,
and we have found that cells depleted for glucose tran-
siently arrest the cell cycle in a Swe1p-dependent man-
ner (data not shown). Thus, in the studies reported here,
all experiments were conducted with cultures at low-
enough cell density to avoid possible stressful effects
of the glucose crash.
Harvey and Kellogg reported that deletion of SWE1 in
the W303 strain background caused an acceleration of
nuclear division in unstressed cells, leading to the birth
of abnormally small daughter cells, which then spent
a longer time in G1 in order to attain the critical size to
pass start [11]. Consistent with this observation, swe1D
mutants in the S288C strain background were identified
in a recent high-throughput screen for mutants with ab-
normally small cell size [26]. In contrast, our previous
studies in the BF264-15D strain background had not de-
tected any effect of deletingSWE1on the cell cycle of un-
stressed cells [27]. To assess the possibility that strain-
background differences are responsible for the apparent
discrepancy, we examined the cell cycle in wild-type and
swe1D W303 strains, kindly provided by D. Kellogg.
We first assessed the relationship between bud size
and nuclear division in unstressed cells. Exponentially
growing cultures of wild-type and swe1D W303 strains
were fixed and stained to visualize nuclei. Randomly
chosen fields of cells were photographed, and the bud
size and nuclear division status of every budded cell
(n > 1000) was scored as described in Experimental Pro-
cedures. As shown in Figure 2A and quantified in Figure
2B, there was considerable variation in the bud size at
which cells underwent nuclear division: The largest
pre-nuclear-division cell had a bud volume of 26 fL,
whereas the smallest post-nuclear-division cell had a
bud volume of 7 fL (Figure 2A). Most cells underwent nu-
clear division with bud sizes in the 10–20 fL range in the
W303 background (Figure 2B) and in the 5–15 fL range
in the BF264-15D background (Figure 3B). Moreover,
we were unable to detect any difference between wild-
type and swe1D cells in the bud size at which cells under-
went nuclear division (Figure 2B). These observations do
not support the existence of a Swe1p-enforced critical
bud size for mitosis.
If deletion of SWE1 does lead to a shortening of G2
and a compensatory lengthening of G1 in daughter cells,
then a proliferating population of swe1D cells should
contain fewer G2/M and more G1 phase cells, as seen
in S. pombe wee1 mutants. We compared the cell-cycle
profiles of proliferating wild-type and swe1D mutant
cells by using flow cytometry, but detected no signifi-
cant difference in the W303, S288C, or BF264-15D strain
backgrounds (data not shown). To specifically assess
the duration of daughter cell G1, we stained cells to visu-
alize bud scars (chitin rings in the cell wall), which are
only present on mother cells [28]. Newborn daughter
cells lack bud scars until just after start, when they de-
posit a chitin ring in preparation for budding. Thus, pre-
start daughter cells are the only cells without bud scars,
and the proportion of scarless cells in an asynchronous
population is directly related to the duration of daughter
cell prestart G1. Exponentially growing cultures of wild-
type and swe1D W303 strains were fixed and stained to
visualize bud scars. As shown in Figure 2C, we detected
no difference between these strains in the proportion of
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Progression during Unperturbed Exponential
Growth
(A) Wild-type (DK186) and swe1D (SH24)
strains were grown to exponential phase in
YEPD at 30ºC, fixed, and stained to visualize
nuclei. Bud size and nuclear-division status
were ascertained microscopically for >1000
budded cells. Individual bud volumes are
plotted on a log scale for cells that had (up-
per) or had not (lower) undergone nuclear di-
vision. n is the number of cells plotted for
each category, and v is the average bud vol-
ume for that category.
(B) Individual bud volumes from (A) were
grouped into size bins as indicated, and the
percentage of cells within each bin that had
undergone nuclear division was calculated.
n > 160 for each bin.
(C) The same strains as in (A) were grown to
exponential phase at 30ºC, fixed, and stained
to visualize bud scars. The percentage of
cells without bud scars, representing prestart
daughter cells, is plotted for strains grown in
YEPD (left) or YEPGE (right). n > 1000. An-
other phenotype of swe1D mutants reported
by Harvey and Kellogg was the presence of
significant numbers (7.5%) of large, multinu-
cleate cells [11]. However, we did not detect
multinucleate cells in exponentially growing
swe1D cultures from any of the three strain
backgrounds examined (data not shown).
(D) Wild-type (DLY7976)andswe1D (DLY7979)
cells were grown to exponential phase at
30ºC, arrested in G1 by pheromone treatment,
and released at 30ºC. Samples were taken at
the indicated times, fixed, and processed to
score buds and spindles as described in Ex-
perimental Procedures. nR 200 cells scored
for each sample.prestart daughter cells. As expected, the proportion of
prestart daughter cells increased when the cells were
grown in media containing a poorer carbon source (glyc-
erol/ethanol, YEPGE), but again there was no difference
between the wild-type and swe1D strains (Figure 2C).
Thus, by using three separate assays (bud size versus
nuclear division, flow cytometry, and proportion of scar-
less cells) on asynchronous populations, we were un-
able to detect any differences in the cell cycle of un-
stressed wild-type and swe1D cells. Coulter electronic
volume measurements of exponentially growing swe1
and wild-type strains also showed little or no difference
in cell volume in three different strain backgrounds
(J. Bean, S. Clairmont, and F. Cross, personal communi-
cation).
Harvey and Kellogg reported that synchronous
populations generated by pheromone arrest-release
displayed a small Swe1p-dependent delay in spindle as-
sembly [11]. We repeated this experiment with deriva-
tives of their strains, and we were able to reproduce
the difference in mitotic timing that they reported (Figure
2D). However, this difference in mitotic events was ex-
actly mirrored by a difference in the timing of bud emer-
gence, a late G1 event that is independent of the B type
cyclins inhibited by Swe1p (Figure 2D) (Harvey and Kel-
logg did not report budding profiles in their experiment).This finding suggested that the strains differed slightly in
the kinetics of recovery from pheromone arrest in G1,
and we found that these particular wild-type and
swe1D strains differed in their pheromone sensitivity
when tested at different pheromone doses (data not
shown). We crossed the wild-type and swe1D strains
and tested the pheromone response of MATa bar1 seg-
regants to a nonarresting dose of pheromone (20 ng/mL
a-factor). Ten out of 16 wild-type segregants and six out
of ten swe1D segregants showed enhanced pheromone
sensitivity, indicating that the difference in sensitivity is
due to a single mutation unlinked to SWE1. We conclude
that the reported mitotic delay was due to an unsus-
pected mutation that affected pheromone sensitivity
and hence the synchrony profile in the strains employed
by Harvey and Kellogg, and not due to an effect of Swe1p
on mitotic progression in unstressed cells.
As described in the Introduction, excess Cln3p causes
cells to bypass start size control, initiating bud formation
at a smaller mother-cell size with less biosynthetic ca-
pacity to promote bud growth [6, 7]. If these buds must
still attain a critical bud size similar to that in wild-type
cells in order to overcome Swe1p, then such cells would
be expected to undergo nuclear division at the same bud
size as wild-type cells. However, we found that cells
containing five copies of CLN3 underwent nuclear
Current Biology
2194Figure 3. Swe1p Does Not Delay Nuclear Di-
vision Even in Small Cells with Excess CLN3
(A) Wild-type (DLY1) and 5xCLN3 (ps2-6c)
strains were grown to exponential phase in
YEPD at 30ºC, fixed, and stained to visualize
nuclei. Bud size and nuclear-division status
were measured as in Figure 2A.
(B) The data from (A) were binned and ana-
lyzed as in Figure 2B. n > 100 for each bin.
(C)Wild-type (DLY1),swe1D (DLY1028),5xCLN3
(ps2-6c), and5xCLN3swe1D (DLY7256,aseg-
regant from a cross between ps2-6c and a
swe1D strain DLY1029) strains were grown
in YEPD at 30ºC, and doubling times were cal-
culated during exponential growth.
(D) The same strains were grown to exponen-
tial phase in YEPD at 30ºC and processed for
flow cytometry. Red indicates SWE1 cells;
blue indicates swe1D cells.division at a significantly smaller bud size than wild-type
cells (Figures 3A and 3B). The average size of post-
nuclear-division buds was 15 fL in 5xCLN3 cells, com-
pared to 21 fL in 1xCLN3 (wild-type) cells.
If Swe1p is important for delaying mitosis in the small
5xCLN3 cells, then deletion of SWE1 would allow those
cells to become even smaller, perhaps leading to lethal-
ity as the cell cycle proceeds rapidly, uncoupled from cell
growth. We tested this possibility by crossing 5xCLN3
cells with swe1D cells. The resulting 5xCLN3 swe1D
double mutants were all viable and indistinguishable
from the 5xCLN3 parents with regard to doubling time
(Figure 3C) and cell-cycle profile (Figure 3D). Thus, even
when bud size is small compared to wild-type cells,
Swe1p does not appear to affect cell-cycle progression
in unstressed cells.
In aggregate, these findings indicate that Swe1p does
not affect cell-cycle progression under our unstressed
exponential-growth conditions. The discrepancy be-
tween these results and those in previous studies is
not due to differences in strain background, but may
stem from unappreciated mutations and/or inadvertent
stresses in the previous work [11].
Why Is Cell-Cycle Arrest upon Lat Treatment
Correlated with Bud Size?
If bud size is not the key determinant of whether or not
cells arrest following Lat treatment, then why do onlysmall-budded, and not large-budded, cells arrest? We
determined that cells lost the capacity to arrest in re-
sponse to Lat shortly before spindle assembly (Figure
4A), which occurs after DNA replication in unstressed
cells [29]. This time represents the crossover between
two waves of timed transcription in the cell cycle (one
wave, including SWE1, peaking in late G1, and the sec-
ond wave, including CLB2, peaking in G2/M) [29]. At
this time, Swe1p abundance is declining while the abun-
dance of the mitotic cyclins Clb1p-Clb4p is increasing
(depicted schematically in Figure 4B). Because mitotic
cyclins are known to promote Swe1p degradation [30,
31], it may be that as cells progress through the cell cy-
cle, the remaining Swe1p simply becomes less capable
of promoting arrest in the face of increasing cyclin pools.
In cells treated with Lat early in the cell cycle, the abun-
dant Swe1p could efficiently inhibit the small pool of
Clb/Cdc28p, and such inhibition would delay the accu-
mulation of further Clb/Cdc28p, which is stimulated by
positive feedback [32]. However, in cells treated with
Lat late in the cell cycle, the less abundant Swe1p would
be confronted with a much larger amount of Clb/Cdc28p
that it may be unable to inhibit. Other factors such as the
activity of the mitosis-promoting phosphatase Mih1p
may also change as cells proceed though the cell cycle,
contributing to a diminished potency of Swe1p to cause
arrest. Thus, we hypothesize that large-budded cells are
unable to undergo cell-cycle arrest in response to Lat
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Governed by Cell-Cycle Progression
(A) Wild-type (DLY7977) cells were synchro-
nized by pheromone arrest/release, and sam-
ples were fixed and processed to score buds
and spindles as described in Experimental
Procedures. In addition, parallel samples
were treated with 100 mM Lat and incubated
until t = 100 min, then fixed with paraformal-
dehyde to visualize GFP-SPBs. The propor-
tion of cells that failed to arrest the cell cycle
in response to Lat was scored by determining
whether the SPBs had undergone anaphase
separation (>2 mm). n R 200 cells scored for
each sample.
(B) Schematic illustrating how the abundance
of Swe1p (blue), Clb2p (red), and the Swe1p/
Clb2p ratio (green) vary through the cell cycle.
Bud volume (black) is also shown for compar-
ison.
(C) Wild-type (DLY1) and clb2D (DLY302)
strains were grown to exponential phase in
YEPD at 30ºC, treated with Latrunculin for
90 min, fixed, and processed to visualize nu-
clei. Bud size and nuclear-division status
were measured as in Figure 2A. clb2D cells
that arrested in Lat despite having buds
larger than any of the wild-type cells that ar-
rested are colored red.
(D) The data from (B) were binned and ana-
lyzed as in Figure 2B. n > 95 for each bin.
(E) 1xSWE1myc (JMY1469) and 2xSWE1myc
(JMY1470) strains were treated and analyzed
as in (C). 2xSWE1myc that arrested in Lat de-
spite having buds larger than any of the
1xSWE1myc cells that arrested are colored
red.
(F) The data from (E) were binned and ana-
lyzed as in (D). n > 125 for each bin.simply because by that time in the cell cycle, the balance
of power has tilted too heavily toward mitotic cyclins and
away from Swe1p.
This hypothesis predicts that increasing Swe1p ex-
pression or decreasing Clb1p-Clb4p expression would
extend the window of the cell cycle during which Swe1p
is able to cause arrest, leading to arrest of larger-budded
cells in response to Lat. As shown in Figures 4C and 4D,
deletion of CLB2 allowed much-larger-budded cells to
arrest nuclear division in response to Lat. Whereas the
largest wild-type cell (n > 800) to arrest in response to
Lat had a bud size of 8 fL, 22% ofclb2Dcells that arrested
had larger buds, extending up to 23 fL (Figure 4C). Simi-
larly, a doubling of the SWE1 gene dosage also allowed
many larger-budded cells to undergo arrest (Figures 4E
and 4F). These findings are fully consistent with an ex-
periment reported by McMillan et al. in 1998 [18], show-
ing that cells expressing more Swe1p can extend the
time in the cell cycle during which Lat exposure leads
to arrest. In aggregate, these data support thehypothesis that the ability of a cell to undergo cell-cycle
arrest in response to Lat depends on the Swe1p-to-
mitotic cyclin ratio, so that as cells proceed through the
cell cycle, they lose the capacity to arrest. Because cell-
cycle progression is correlated with bud growth, small-
budded cells are more likely than large-budded to arrest,
but it is not bud size that directly controls arrest.
Conclusions
Multiple stresses that impair bud growth also cause
Swe1p-dependent cell-cycle delay or arrest [16–18, 23,
33]. Previous studies interpreted these findings in terms
of a morphogenesis checkpoint that responded to per-
turbation of actin [18], septins [34, 35], or bud emergence
[23]. The hypothesis that yeast cells can monitor bud size
and restrain mitosis with Swe1p until a critical bud size
has been reached provided an appealingly simple and
potentially unifying explanation for these phenomena
[11]. However, we report here that unlike actin depoly-
merization, blocking bud growth by inactivating myosin
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Strain Relevant Genotype Strain Background Source
ABY551 a/a MYO2::HIS3/MYO2::HIS3 ABY551 [21]
ABY553 a/a myo2-16::HIS3/myo2-16::HIS3 ABY551 [21]
BY4743 a/a S288C Research Genetics
DK186 a bar1 W303 [11]
DLY1 a bar1 BF264-15D [27]
DLY302 a clb2::LEU2 bar1 BF264-15D [41]
DLY657 a cdc24-1 bar1 BF264-15D [27]
DLY690 a cdc24-1 swe1::LEU2 bar1 BF264-15D [27]
DLY1028 a swe1::LEU2 BF264-15D [27]
DLY1029 a swe1::LEU2 BF264-15D This study
DLY6600 a MYO2::HIS3 swe1::kanr ABY551 This study
DLY6603 a myo2-16::HIS3 bar1::URA3 ABY551 This study
DLY6652 a MYO2::HIS3 swe1::kanr bar1::URA3 ABY551 This study
DLY6653 a myo2-16::HIS3 swe1::kanr bar1::URA3 ABY551 This study
DLY6712 a MYO2::HIS3 bar1::URA3 ABY551 This study
DLY7256 a 5xCLN3::TRP1 swe1::LEU2 BF264-15D This study
DLY7976 a bar1 SPC42-GFP::TRP1 W303 This study
DLY7977 a bar1 SWE1myc:HIS2 SPC42-GFP::TRP1 BF264-15D This study
DLY7979 a bar1 swe1::URA3 SPC42-GFP::TRP1 W303 This study
JHX204-1A a swe1::kanr S288C Research Genetics
JMY1469 a SWE1myc:HIS2 bar1 BF264-15D [42]
JMY1470 a SWE1myc:HIS2 SWE1myc:TRP1 bar1 BF264-15D [42]
JMY1786 a S288C This study
Ps2-6c a 5xCLN3::TRP1 bar1 BF264-15D Fred Cross
SH103 a swe1::URA3 W303 Doug Kellogg
SH24 a bar1 swe1::URA3 W303 [11]function did not lead to Swe1p-mediated arrest even in
cells with tiny buds. Moreover, unstressed cells do not
experience Swe1p-mediated cell-cycle delays even
when buds are small. Thus, we conclude that Swe1p re-
sponds to perturbations affecting the cytoskeleton,
rather than monitoring bud size. Furthermore, our find-
ings suggest that Swe1p can respond to such perturba-
tions even at larger bud sizes and that the failure of large-
budded cells to arrest following actin depolymerization
is due to accumulation of too much cyclin for the remain-
ing Swe1p to inhibit.
Experimental Procedures
Media, Growth Conditions, Synchrony, and Latrunculin
Treatment
Cells were grown in YEPD (1% yeast extract, 2% Bacto Peptone;
supplemented with 2% Dextrose and 0.01% adenine following ster-
ilization by autoclaving), YEPGE (2% Glycerol and 2% Ethanol in-
stead of 2% Dextrose), or synthetic complete medium without histi-
dine, as indicated. Cells were grown with constant agitation at the
indicated temperature for at least 10 generations (so that starting
cells represent% 0.1% of the population analyzed) to a final density
of% 8 3 106 cells/mL (so that growth is still exponential with abun-
dant nutrients: Cell density upon reaching stationary phase was
generallyR 5 3 108 cells/mL).
For the experiments involving pheromone arrest/release syn-
chrony (Figures 2D and 4A), exponentially growing cells were ar-
rested by treatment with 40 ng/mL a-factor for 2.5 hr at 30ºC, har-
vested by centrifugation, and resuspended in prewarmed fresh
YEPD at 5 3 106 cells/mL at 30ºC.
For experiments involving Latrunculin treatment, cells were
treated with 100 mM Latrunculin B (Biomol Reasearch Laboratories,
Plymouth Meeting, Pennsylvania, diluted from a 10 mM stock in di-
methyl sulfoxide) or with dimethyl sulfoxide alone as control, and
they were incubated with agitation for the indicated times prior to fix-
ation and analysis as described below.
Strain Construction
Standard yeast genetic methods were used to generate new strains.
All strains used in this study are listed in Table 1. The 5xCLN3 strainwas a kind gift from Fred Cross (The Rockefeller University, New
York). The bar1::URA3 allele was introduced into yeast by a PCR
knockout strategy [36], amplifying URA3 from a pRS306 template
[37] with primers OJ29 (ACACTGCCCGAATTTGCCATAGTCGAGGA
TAATTCTAATTTAGTTTCCTGATGCGGTATTTTCTCCT) and OJ28-2
(CCATTACTGCTTTAACAAACGATGGCACTGGTCACTTAGAGCGC
GTTTCGGTGATGAC); successful integration was confirmed by
PCR. The swe1::kanr allele was transferred from strain JHX204-1A
via a PCR product amplified from genomic DNA with primers OJ21
(ATCATCTTGCGCAGTTAGTCCA) and Z164 (GTTGTTATCTGCTAC
ATCTG); integration was confirmed by PCR. In both cases, transfor-
mations were carried out in ABY551-strain-background diploids and
followed by sporulation and (if necessary) crosses within that strain
background to generate the desired haploids. The wild-type S288C
MATa strain (JMY1786) was generated by sporulation of BY4743, an
S288C diploid.
Strains DLY7976, 7977, and 7979 were generated by integrating a
pRS304-SPC42-GFP plasmid from Steve Haase (Duke University) at
the TRP1 locus in strains DK186, JMY1469, and SH24, respectively.
Microscopy
Exponentially growing cells were fixed by addition of ethanol to 70%
(vol/vol), incubated overnight at 4ºC, harvested by centrifugation,
and stained to visualize DNA or bud scars. For DNA staining, cells
were resuspended in phosphate-buffered saline (PBS: 137 mM
NaCl, 2.7 mM KCl, 8.0 mM NaHPO4, 1.5 mM KH2PO4, pH 7.5) with
0.3 mg/mL 40-6-Diamidino-2-phenylindole (DAPI: Sigma Chemical,
St. Louis, Missouri) and incubated for 5 min at room temperature,
then diluted 10-fold and sonicated. For bud-scar staining, cells
were resuspended in distilled water with 100 mg/mL Calcofluor (Fluo-
rescent Brightener 28, Sigma Chemical Co) and incubated for 15 min
at room temperature, then washed with water. In both cases, cells
were then harvested, resuspended in mounting media [38, 39], and
placed onto slides with 2% agarose pads in PBS to immobilize
them. Cells were viewed on a Zeiss Axioscop with a 1003 objective
with differential interference contrast and fluorescence optics. Im-
ages were captured with a charge-coupled device camera and ana-
lyzed with Metaporph software. Bud volume (v) was estimated based
on measured bud length (l) and width (w) with the formula for an ob-
late spheroid (v = plw2/6) and NIH image software.
To monitor the kinetics of spindle assembly and anaphase in syn-
chronous populations, we fixed cells containing an integrated
SPC42-GFP with paraformaldehyde (2% final concentration) for
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219715 min at room temperature, then harvested and resuspended them
in PBS for storage at 4ºC. Cells were resuspended in mounting me-
dia, and spindle pole bodies were visualized by GFP fluorescence.
Spindle assembly was scored as the appearance of two separate
GFP spots, and anaphase as the separation of the spots to >> 2
mm apart.
Flow Cyctometry
Processing for flow cytometry was essentially as described [40]. Ex-
ponentially growing cells were fixed by addition of ethanol to 70%
(vol/vol), incubated overnight at 4ºC, harvested by centrifugation,
and resuspended in 50 mM Tris (pH 8.0) containing 2 mg/mL freshly
boiled RNase A (Sigma Chemical). After >2 hr at 37ºC, cells were har-
vested, resuspended in 5 mg/mL Pepsin (Sigma Chemical) in 0.45%
HCl (vol/vol), incubated for 15 min at 37ºC, then harvested and re-
suspended in 50 mM Tris (pH 8.0) and sonicated. Cells were stained
by addition of 1 mM Sytox Green (Molecular Probes, Eugene, Ore-
gon) for >15 min at room temperature and analyzed on a Becton-
Dickinson FACScan. Ten thousand events were recorded for each
sample and plotted with Cellquest (Becton Dickinson Immunocy-
tometry Systems, Palo Alto, California) software.
Scoring Cell-Cycle Arrest
For the experiments of Figures 1A–1C, cells growing exponentially in
synthetic complete medium lacking histidine at 24ºC were treated in
various ways and then scored to assess what proportion of budded
preanaphase cells in the starting population subsequently failed to
proceed through nuclear division (i.e., the percent of budded cells
that were still preanaphase at the relevant time point). To provide
a control for the rate at which wild-type untreated cells prog-
ress through the cell cycle, we used MATa bar1 cells and added
100 ng/mL a-factor to all cultures to prevent formation of new buds.
a-factor arrests prestart cells in G1 but has no effect on the cell cycle
of poststart cells until they reach G1 of the next cell cycle [29]. Bud-
ding occurs about 15 min after start, so once the cells have been ex-
posed toa-factor for 15 min, no new buds will emerge: This is consid-
ered t = 0 in Figures 1A–1C. At that time, cells were shifted to 37ºC
(leading to inactivation of Myo2p inmyo2-16 strains), and where indi-
cated, samples were treated with Latrunculin as described above.
Untreated wild-type cells proceed through the cell cycle, and be-
cause no new buds are generated, the proportion of budded preana-
phase cells declines from its starting value to zero within 90 min, as
illustrated in Figure 1A.
To accurately score the proportion of the starting preanaphase
cells that had arrested (or not yet undergone nuclear division) at var-
ious times, we scored cell bodies (each mother or bud is counted as
one cell body) rather than budded cells. This method avoids the con-
founding effect of the cell-number change that occurs when a bud-
ded cell divides to form two unbudded cells. Because there is no
new bud formation after t = 0, the number of cell bodies is constant
throughout the time course. Budded preanaphase cells were scored
as two cell bodies with one nucleus, whereas budded postanaphase
cells were scored as two cell bodies with two nuclei (regardless of
whether the nuclei had segregated correctly). Unbudded cells were
scored as one cell body with one nucleus. A preanaphase cell index
was then calculated as follows:
Preanaphase index = ð# cell bodies2# nucleiÞ=# cell bodies
To obtain the percentage of budded preanaphase cells remaining
at any specified time, we divided the preanaphase index at that time
by the preanaphase index at t = 0 (y axis, Figures 1A and 1B).
For the a-factor arrest/release experiment of Figure 1D, cells
growing exponentially at 24ºC were arrested in G1 by treatment
with 100 ng/mL a-factor for 2.5 hr, harvested by centrifugation,
and resuspended in fresh medium at 37ºC. Cells were fixed and
stained to visualize DNA as described above.
Scoring Doubling Time
Triplicate cultures of each strain were grown in YEPD at 30ºC, and
measurements of OD600 were made hourly for 9 hr. From the expo-
nential portion of the growth curve (OD600 0.004 to 0.72), doubling
times were calculated from the best-fit exponentials obtained with
Kaleidagraph (Synergy software, Reading, Pennsylvania).Acknowledgments
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